sr141716 has been researched along with C gattii Infection in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Chang, W; Chen, J; Duan, X; Jin, X; Lin, Z; Lou, H; Lu, J; Pang, Y; Wang, X; Zhang, M | 1 |
1 other study(ies) available for sr141716 and C gattii Infection
Article | Year |
---|---|
Rimonabant potentiates the antifungal activity of amphotericin B by increasing cellular oxidative stress and cell membrane permeability.
Topics: Amphotericin B; Animals; Antifungal Agents; Biofilms; Candida albicans; Candidemia; Cell Membrane Permeability; Cryptococcosis; Cryptococcus neoformans; Drug Synergism; Fungi; Male; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Oxidative Stress; Rimonabant; Small Molecule Libraries | 2021 |